Advocacy   |   ASGCT News

ASGCT Heats Up in Summer 2019

Maritza McIntyre, Ph.D. - June 14, 2019

Up-to-date clinical trials info and a new policy-centered event keep up the post-meeting momentum.

The summer has historically been a slow period for ASGCT, but that’s changed in recent years. As one of the newly-elected members of the Society’s board of directors, I’m proud to say ASGCT is now just as busy in June as it is in January.

Recently, the Society launched the ASGCT Clinical Trials Finder, the only curated, interactive tracking system for gene and cell therapy clinical trials recruiting in the United States. This customizable search engine allows users to explore active clinical trials across the field based on nearly a dozen user-decided criteria.

The launch of the ASGCT Clinical Trials Finder comes at the perfect time as NIH begins phasing out their Genetic Modification Clinical Research Information System, which served a similar purpose. NIH has committed to make stakeholders aware of the resource and ASGCT will work to migrate users of the GeMCRIS system to the ASGCT service.

On behalf of ASGCT, thank you to all of the committee members, stakeholder groups, and Society members who lent their time and expertise to make this important project a reality. We're looking forward to hearing your thoughts on this new tool. Tell us about your experience by emailing

ASGCT is also hard at work on a second, mid-cycle event opposite the ASGCT Annual Meeting. The ASGCT Policy Summit (November 4 – 6 at The Westin in Washington, D.C.) will gather scientific, regulatory, and bioethical communities for three days of discussion focusing on global regulation, payment policies, and the ethics of germline gene editing.

Each day covers one of the aforementioned topics and can be registered for individually to provide stakeholders flexibility.  The schedule breakdown is as follows:

  • November 4: Global Regulatory Issues in Gene Therapy Development
  • November 5: Perspectives on Payment Policies
  • November 6: Scientific, Ethical, and Societal Issues in Germline Gene Editing

Additional programming and speaker information will be released on prior to the opening of ASGCT Policy Summit registration on July 8.

I’m looking forward to sharing all of the great initiatives we’re undertaking at ASGCT and hope to see many of you at the summit this November.

Related Articles


Dr. Terence Flotte Calls for CGT Investment and Collaboration During Congressional Testimony

Read Dr. Flotte's testimony + watch the hearing - February 29, 2024

Mohamed Abou-el-Enein Appointed Editor of Molecular Therapy Methods and Clinical Development

Dr. Abou-el-Enein began five-year term Jan. 1. - January 04, 2024

For Members, ASGCT Has More Programming, Research Funding, and Opportunities Than Ever

Join the largest CGT community - October 03, 2023

Drew Weissman & Katalin Karikó to Co-Receive 2023 Nobel Prize for Discoveries in mRNA Technology

October 02, 2023